A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2
150
about 1.6 years
18+
36 sites in AL, AZ, CA +15
About this study
This trial is testing a treatment called LY4065967 for people with diabetic peripheral neuropathic pain. The goal is to see if this treatment is safe and effective.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take LY4065967
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)
Secondary: Change From Baseline in the Brief Pain Inventory-Short Form Modified (BPI-SFM) Total Pain Interference Score, Change from Baseline in Emotional Functioning as Measured by the EuroQol-5D 5 Level Questionnaire (EQ 5D 5L), Change from Baseline in Overall Improvement as Measured by Patient's Global Impression of Change (PGI-C), Change from Baseline in Sleep Scale from the Medical Outcomes Study (MOS Sleep Scale), Change from Baseline in Worst Pain Intensity as Measured by NRS